Thoracic sarcopenia as a predictive factor of SARS-COV2 evolutionArticle Published on 2022-12-012023-07-08 Journal: Clinical nutrition (Edinburgh, Scotland) [Category] COVID19(2023년), [키워드] COVID Malnutrition sarcopenia SARS-CoV2 SMD SMI [DOI] 10.1016/j.clnu.2022.01.022 PMC 바로가기
Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regressionArticle Published on 2022-11-012022-11-15 Journal: Clinical and experimental medicine [Category] 바이오마커, [키워드] 95% CI Admission alteration Analysis Biomarker certainty of evidence Concentration conducted coronavirus disease COVID-19 COVID-19 patients COVID-19 severity disease severity effect size Egger estimates heterogeneity hospitalized COVID-19 patient hydroxybutyrate hydroxybutyrate dehydrogenase Inflammation Injury Liver damage magnitude marker Meta-analysis meta-regression moderate Mortality Myocardial myocardial injury non-specific non-survivor Patient performed renal renal function reported risk stratification searched Sepsis serum severity significantly significantly higher SMD standardized mean difference survival survivor systematic review tissue damage Web of Science [DOI] 10.1007/s10238-021-00777-x PMC 바로가기
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trialsArticle Published on 2022-11-012022-11-15 Journal: European Journal of Clinical Pharmacology [Category] SARS, 치료제, [키워드] 95% CI 95% confidence interval addition anti-inflammatory effect antiparasitic antiviral activity blinded clinical benefit continuous variable COVID-19 D-dimer D-dimer level death dichotomous variable Disease progression Effect effect size Efficacy and safety element eligibility enrolled Evidence Frequency ICU admission in vitro individual Inflammation Invasive mechanical ventilation lactate dehydrogenase LDH magnitude Meta-analysis Mild moderate Moderate COVID-19 nitazoxanide no difference Patient patients peer-reviewed performed Placebo placebo-controlled positive positive RT-PCR Primary outcome randomized clinical trial RCT RCTs receiving reducing reduction in reported risk SARS-CoV-2 SARS-COV-2 infection secondary outcome serum biomarker SMD standardized mean difference systematic review tested to define treat treated Viral load WBC were used White blood cell with COVID-19 [DOI] 10.1007/s00228-022-03380-5 PMC 바로가기
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysisArticle Published on 2022-09-132022-11-15 Journal: Frontiers in Immunology [Category] 변종, 진단, [키워드] 95% confidence interval Adults adverse event AEs analyzed booster caused Cochrane Library control group control groups Controlled trial coronavirus disease Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines DNA vaccines dose Efficacy eligible Factor Factors Fever follow-up period geometric mean titer GMT Health highest immunogenicity inactivated incidence Increased Local Meta-analysis meta-regression analysis mRNA vaccine Neutralizing antibodies Older older adult Older adults outcome Pain provided random-effect Randomized controlled trial randomized controlled trials (RCTs) Registered required Research risk Safety searched seroconversion rate severe disease significantly increased SMD standardized mean difference Strains Surveillance susceptible systematic review systemic AEs Universal vaccination Vaccine variant Web of Science [DOI] 10.3389/fimmu.2022.965971 PMC 바로가기
The complexity of examining laboratory-based biological markers associated with mortality in hospitalized patients during early phase of the COVID-19 pandemic: A systematic review and evidence mapArticle Published on 2022-09-092022-11-15 Journal: PLoS ONE [Category] 바이오마커, 진단, [키워드] 95% CI appraisal association biological marker Biomarker Biomarkers Blood urea nitrogen China Clustering conducted country COVID-19 Critical early phase effect sizes Evidence glomerular filtration rate heterogeneity hospital hospitalized patient hospitalized patients IL-6 include Inflammatory Joanna Briggs Institute laboratory biomarker limit methodology Mortality multiple study overlapping pandemic Patient patients hospitalized patients with COVID-19 Quality renal screened searched Sery SMD standardized mean difference systematic review Web of Science were used with COVID-19 [DOI] 10.1371/journal.pone.0273578 PMC 바로가기
Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysisResearch article Published on 2022-09-012022-10-05 Journal: International immunopharmacology [Category] 임상, [키워드] 95% CI adjuvant therapy Admission adverse event article benefit C-reactive protein case control study clinical Cochrane Library conducted COVID-19 COVID-19 patients CRP D-dimer D-dimer levels decrease endpoints evaluate Hospital stay ICU ICU admission IL-6 IMPROVE improvement integrative medicine intensive care Laboratory laboratory parameter lactate dehydrogenase LDH management Meta-analysis Mortality objective outcomes Ozone ProQuest random-effects Randomized controlled trial RCTs reduction reported Result safety profile SARS-CoV-2 Serious Adverse Event severe patients Side effect significantly SMD Standard therapy suggested systematic review therapy viral clearance were assessed [DOI] 10.1016/j.intimp.2022.109014 [Article Type] Research article
The Associations of Iron Related Biomarkers with Risk, Clinical Severity and Mortality in SARS-CoV-2 Patients: A Meta-AnalysisSARS-CoV-2 환자의 위험, 임상 중증도 및 사망률과 철분 관련 바이오마커의 연관성: 메타 분석Review Published on 2022-08-192022-09-11 Journal: Nutrients [Category] SARS, 바이오마커, 치료기술, [키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition article Biomarker calculation caused clinical coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 progression deaths disease Diseases eligible evaluate Evidence ferritin ferritin level ferritin levels hemoglobin heterogeneity indicate Infection iron Iron metabolism magnitude mean difference Meta-analysis metabolism Mortality non-survivor Non-survivors Occurrence opposite Patient peer-reviewed Previous studies previous study progression random effect respiratory risk SARS-CoV-2 searched serum severe acute respiratory syndrome Coronavirus severity significantly lower SMD Survivors the disease TIBC was used Web of Science with COVID-19 [DOI] 10.3390/nu14163406 PMC 바로가기 [Article Type] Review
SARS-CoV-2 effects on sperm parameters: a meta-analysis studySARS-CoV-2가 정자 매개변수에 미치는 영향: 메타 분석 연구Review Published on 2022-07-012022-09-11 Journal: Journal of Assisted Reproduction and Genetics [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% confidence interval applied association case control studies Concentration coronavirus disease Coronavirus disease 2019 COVID-19 database Effect Effects evaluate Google Scholar Health identify Impact indicated infertility investigated male male infertility male reproduction male reproductive system mean difference Meta-analysis outbreak pandemic parameter parameters Patient performed publication bias reproductive reproductive system Research retrospective cohort study SARS-CoV-2 SARS-COV-2 infection searched Semen Semen parameters. sensitivity analysis significantly SMD Sperm sperm count sperm motility standardized mean difference suggested Volume vulnerability Web of Science [DOI] 10.1007/s10815-022-02540-x PMC 바로가기 [Article Type] Review
Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysisReview article Published on 2022-07-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 바이오마커, 임상, [키워드] 95% confidence interval adipose Adiposity Adverse adverse outcome chronic obstructive CIs Clinical outcome Computed tomography Control Coronary artery disease COVID-19 COVID-19 severity database diabetes Effect Epicardial adipose tissue help Hospitalization independent intensive care Invasive mechanical ventilation mean difference measure Meta-analysis objective Patient patients with COVID-19 poor prognosis positive primary end point Prognosis prognostic risk stratification pulmonary disease Quantitative Result risk factor Risk factors searched severe group severity SMD tissue visceral [DOI] 10.1016/j.ijid.2022.04.013 [Article Type] Review article
Effect of Pulmonary Rehabilitation Approaches on Dyspnea, Exercise Capacity, Fatigue, Lung Functions, and Quality of Life in Patients With COVID-19: A Systematic Review and Meta-analysisReview article Published on 2022-07-012022-10-05 Journal: Archives of physical medicine and rehabilitation [Category] 임상, [키워드] 6-minute walk test 6MWT6-minute walk test 95% CI acute COVID-19 appear Capacity chronic obstructive pulmonary disease Controlled trial COPDchronic obstructive pulmonary disease COVID-19 COVID-19 patients database Dyspnea Effect effective evaluate the effect evaluated exercise Exercise capacity extraction fatigue feasible forced vital capacity functions FVCForced vital capacity independent indicate Intervention life lung Lung function mean difference Mild mild symptoms objective outcome outcome measure participant Patient patients with COVID-19 PRpulmonary rehabilitation pulmonary pulmonary rehabilitation QoLquality of life Quality Quality of life random effect Randomized controlled trial RCT RCTrandomized controlled trial RCTs review risk of bia Safe searched Selection severe symptoms SFShort-Form Health Survey SGRQSt. George's Respiratory Questionnaire Short-Form Health Survey significantly SMD Source St. George's Respiratory Questionnaire synthesis ventilatory Web of Science [DOI] 10.1016/j.apmr.2022.06.007 [Article Type] Review article